MA45752B2 - Steroids and their protein conjugates - Google Patents
Steroids and their protein conjugatesInfo
- Publication number
- MA45752B2 MA45752B2 MA45752A MA45752A MA45752B2 MA 45752 B2 MA45752 B2 MA 45752B2 MA 45752 A MA45752 A MA 45752A MA 45752 A MA45752 A MA 45752A MA 45752 B2 MA45752 B2 MA 45752B2
- Authority
- MA
- Morocco
- Prior art keywords
- steroids
- protein conjugates
- protein
- conjugates
- glucocorticoids
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des conjugués de stéroïdes protéiques qui sont utiles, par exemple, pour l'administration spécifique à une cible de glucocorticoïdes (gc) à des cellules.Disclosed herein are protein steroid conjugates which are useful, for example, for the target-specific delivery of glucocorticoids (gc) to cells.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662419365P | 2016-11-08 | 2016-11-08 | |
PCT/US2017/060434 WO2018089373A2 (en) | 2016-11-08 | 2017-11-07 | Steroids and protein-conjugates thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MA45752A1 MA45752A1 (en) | 2020-06-30 |
MA45752B2 true MA45752B2 (en) | 2022-12-30 |
Family
ID=72291376
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA51971A MA51971B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
MA51969A MA51969B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
MA45752A MA45752B2 (en) | 2016-11-08 | 2017-11-07 | Steroids and their protein conjugates |
MA51970A MA51970B1 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA51971A MA51971B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
MA51969A MA51969B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA51970A MA51970B1 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2023000971A1 (en) |
MA (4) | MA51971B2 (en) |
-
2017
- 2017-11-07 MA MA51971A patent/MA51971B2/en unknown
- 2017-11-07 MA MA51969A patent/MA51969B2/en unknown
- 2017-11-07 MA MA45752A patent/MA45752B2/en unknown
- 2017-11-07 MA MA51970A patent/MA51970B1/en unknown
-
2023
- 2023-04-04 CL CL2023000971A patent/CL2023000971A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA51971A1 (en) | 2022-06-30 |
MA51969A1 (en) | 2022-08-31 |
MA51971B2 (en) | 2024-05-31 |
MA45752A1 (en) | 2020-06-30 |
MA51970B1 (en) | 2023-11-30 |
CL2023000971A1 (en) | 2023-09-29 |
MA51970A1 (en) | 2022-08-31 |
MA51969B2 (en) | 2024-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50259A1 (en) | Steroids and their antibody conjugates | |
MA45029B1 (en) | Anti pd-1 and anti-lag3 antibodies for cancer treatment | |
MX2023014120A (en) | Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods. | |
MD3804737T2 (en) | Compositions comprising bacterial strains | |
MX2020001270A (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies. | |
MX2023011657A (en) | Compositions comprising curons and uses thereof. | |
MA41937B1 (en) | DRUG CONJUGATES INCLUDING CLAUDINE ANTIBODIES 18.2 | |
MX2021000965A (en) | Compositions comprising circular polyribonucleotides and uses thereof. | |
BR112018016450A2 (en) | vcn enhancer compositions and methods of using them | |
MA40662B1 (en) | Antibodies against tigit | |
MA40132A1 (en) | Macrocyclic Inhibitors of Protein / protein Interactions pd-1 / pd-11 and cd80 (b7-1) / pd-li | |
MA47392A1 (en) | Bis-octahydrophenanthrene carboxamides and their protein conjugates | |
CY1124704T1 (en) | SOBETIROME PRODUCT | |
CL2019002251A1 (en) | Antibodies against tryptase, compositions of these and uses of these. | |
BR112021016056A2 (en) | Claudin 6 antibodies and their uses | |
BR112018009004A8 (en) | anti-cd3-folate conjugates and their uses | |
MX2020013389A (en) | Terlipressin compositions and uses thereof. | |
UY37800A (en) | IRNA AGENTS FOR THE INHIBITION OF ALFA-ENaC EXPRESSION AND METHODS OF USE | |
MX2020011027A (en) | Trivalent trispecific antibody constructs. | |
WO2019036725A3 (en) | Tau aggregation peptide inhibitors | |
MA51969A1 (en) | Steroids and their protein conjugates | |
MX2021006941A (en) | Anellosomes for delivering intracellular therapeutic modalities. | |
EA201900275A1 (en) | STEROIDS AND THEIR PROTEIN CONJUGATES | |
MA51297B1 (en) | Quinazolinones as parp14 inhibitors | |
EA202090234A1 (en) | RNAi MEANS FOR INHIBITING ALPHA-ENaC EXPRESSION AND METHODS OF APPLICATION |